Aarkstore Enterprise-Mesenchymal Stem Cells, Advances & Applications
This is an expanded and updated report that includes:
55 New Pages of Material
Charts, Timelines, Metrics and Financials Updated for 2011
5-Year Projection Data Spanning 2011-2016
Expanded Competitive Environment Analysis
New Section Presenting End-User Preferences (Scientist Panel)
Overview: Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of increase is projected to accelerate in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.
BioInformant has been following the mesenchymal stem cell market since it was a minor market trend.
As a result of escalating demand for MSC research, research tools and therapeutic solutions,
BioInformant launched a broadly expanded version of the market report,
Mesenchymal Stem Cells, Advances & Applications,
Published January 2011.
Highlights of the publication include:
Detailed characterization of the market, emphasizing statistical trend assessment,Exploration of recent product evolution and projected directions for development
Data on end-user interests, needs and technical preferences (Scientist Panel)
Overview of Therapeutic Progress
Insight into Future Applications
Detailed Evaluation of Profit Opportunities
And Much More…
The report explores why no other stem cell type has experienced comparable demand increase among researchers. Is there a momentum effect?
Are fundamentals driving the trend?
Most importantly, what profit opportunities does this trend represent?
The timing of this report is designed to assist companies with annual planning and strategic decision-making to make 2011 a profitable year.
I. Abstract
II. Overview
A. Definition
B. Alternative Names and Nomenclature
C. Criteria for Identifying
1. Physical Characteristics
2. Functional Attributes
D. Benefits Relative to Other Stem Cells
III. Isolation Sources
A. Adult
B. Fetal
IV. Cell Types Derived from MSCs
V. Applications
A. Basic Research Applications
1. Directed Differentiation of MSCs into Intra-Mesenchymal Lineages
2. Directed Differentiation of MSCs into Extra-Mesenchymal Lineages
B. Supporting Hematopoietic Cells
C. Gene Transfer Applications
D. Cell Transplantation for Site-Specific Repair
1. Overview
2. Major Applications
a. Osteogenic Repair
b. Myogenic and Myocardial Repair
c. Neural Repair
d. Pancreatic Repair
E. Topical Therapy and Use of MSCs in Wound Healing
F. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications
G. Drug Delivery Applications: Engineered MSCs as specific carriers of anti-cancer drugs
H. Drug Screening
I. MSC-mediated Inhibition of Immune Effector Cells
For more information, please visit : http://www.aarkstore.com/reports/Mesenchymal-Stem-Cells-Advances-Applications-32470.html
55 New Pages of Material
Charts, Timelines, Metrics and Financials Updated for 2011
5-Year Projection Data Spanning 2011-2016
Expanded Competitive Environment Analysis
New Section Presenting End-User Preferences (Scientist Panel)
Overview: Analysis of global grant activity, scientific publication rates, and patent applications reveal that research activity involving mesenchymal stem cells increased 58% year-over-year from 2008 to 2009, and 112% from 2009 to 2010. Of most interest is that this rate of increase is projected to accelerate in 2011, making mesenchymal stem cells the fastest growing area of stem cell research.
BioInformant has been following the mesenchymal stem cell market since it was a minor market trend.
As a result of escalating demand for MSC research, research tools and therapeutic solutions,
BioInformant launched a broadly expanded version of the market report,
Mesenchymal Stem Cells, Advances & Applications,
Published January 2011.
Highlights of the publication include:
Detailed characterization of the market, emphasizing statistical trend assessment,Exploration of recent product evolution and projected directions for development
Data on end-user interests, needs and technical preferences (Scientist Panel)
Overview of Therapeutic Progress
Insight into Future Applications
Detailed Evaluation of Profit Opportunities
And Much More…
The report explores why no other stem cell type has experienced comparable demand increase among researchers. Is there a momentum effect?
Are fundamentals driving the trend?
Most importantly, what profit opportunities does this trend represent?
The timing of this report is designed to assist companies with annual planning and strategic decision-making to make 2011 a profitable year.
I. Abstract
II. Overview
A. Definition
B. Alternative Names and Nomenclature
C. Criteria for Identifying
1. Physical Characteristics
2. Functional Attributes
D. Benefits Relative to Other Stem Cells
III. Isolation Sources
A. Adult
B. Fetal
IV. Cell Types Derived from MSCs
V. Applications
A. Basic Research Applications
1. Directed Differentiation of MSCs into Intra-Mesenchymal Lineages
2. Directed Differentiation of MSCs into Extra-Mesenchymal Lineages
B. Supporting Hematopoietic Cells
C. Gene Transfer Applications
D. Cell Transplantation for Site-Specific Repair
1. Overview
2. Major Applications
a. Osteogenic Repair
b. Myogenic and Myocardial Repair
c. Neural Repair
d. Pancreatic Repair
E. Topical Therapy and Use of MSCs in Wound Healing
F. Use of MSC in 3-D Scaffolds for Tissue Engineering Applications
G. Drug Delivery Applications: Engineered MSCs as specific carriers of anti-cancer drugs
H. Drug Screening
I. MSC-mediated Inhibition of Immune Effector Cells
For more information, please visit : http://www.aarkstore.com/reports/Mesenchymal-Stem-Cells-Advances-Applications-32470.html
